Express Scripts-Medco Merger Closes With No Divestitures Needed
This article was originally published in The Pink Sheet Daily
Executive Summary
The FTC voted in a split 3-1 vote to close its investigation and allow Express Scripts’ $29.1 billion acquisition of rival PBM Medco to proceed.
You may also be interested in...
FTC Scrutiny Of Profit Seeking In Drug Supply Chain In Fact-Finding Mode
Agency hears from experts on whether PBMs and group purchasing organizations operate under misaligned incentives.
Rite Aid To Gain Specialty Drug, Part D Platforms With PBM EnvisionRx
The drug store chain will purchase EnvisionRx, which serves over 21 million members and expects to manage 145 million pharmacy claims in 2015, for $2 billion in cash and stock.
Humana Weighing Drug Purchasing Change With PBM “Strategic Review”
The insurer is considering strategic options for its internal PBM, which manages more than 300 million drug claims for more than 9 million individuals, mainly in the Medicare space.